Japan Gene Therapy Market Report by Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide Gene, Deficiency, Growth Factors, Receptors, and Others), Vector Type (Viral Vector, Non-Viral Techniques), Delivery Method (In-Vivo Gene Therapy, Ex-Vivo Gene Therapy), Application (Oncological Disorders, Rare diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Others), and Region 2024-2032

Japan Gene Therapy Market Report by Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide Gene, Deficiency, Growth Factors, Receptors, and Others), Vector Type (Viral Vector, Non-Viral Techniques), Delivery Method (In-Vivo Gene Therapy, Ex-Vivo Gene Therapy), Application (Oncological Disorders, Rare diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A9327
Buy Now

Market Overview:

The Japan gene therapy market size is projected to exhibit a growth rate (CAGR) of 15.1% during 2024-2032 The escalating prevalence of genetic disorders, recent advancements in gene editing technologies, implementation of supportive policies by the Government of Japan, and the increasing investment in research and development (R&D) represent some of the key factors driving the market.

Report Attribute 
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Growth Rate (2024-2032) 15.1%


Gene therapy is a groundbreaking approach in the medical field, designed to address and potentially eradicate diseases through the modification of genes within an individual's cells. This advanced technique encompasses the introduction, deletion, or alteration of genetic material in a patient's cells, with the primary aim of rectifying the genetic anomalies causing various diseases. The essential components of gene therapy include therapeutic deoxyribonucleic acid (DNA), a delivery vector that facilitates the transfer of DNA into cells, and sophisticated gene-editing technologies, such as CRISPR. It finds application across numerous domains, including cancer treatment, management of viral infections, tackling cardiovascular diseases (CVDs), neurological disorders, autoimmune diseases, age-related illnesses, specific types of blindness, and genetic disorders, including hemophilia, cystic fibrosis, and sickle cell disease.

Japan Gene Therapy Market Trends:

The escalating prevalence of genetic disorders and cancers in Japan, which has prompted the need for innovative treatment methods, such as gene therapy, is propelling the market growth. Additionally, the recent advancements in gene editing technologies such as CRISPR/Cas9, which have improved the accuracy of gene modifications and enhanced the success rates of therapies, are contributing to the market growth. Furthermore, the substantial investments in research and development (R&D) activities by pharmaceutical and biotech companies to develop effective and innovative gene therapies are boosting the market growth. Along with this, the implementation of supportive regulations and policies by the Government of Japan to accelerate approval processes and promote gene therapy trials and products is stimulating the market growth. Besides this, the emergence of advanced vector delivery systems, which improve gene therapy's efficacy and minimize potential side effects, thus ensuring more effective and safer treatment options, is supporting the market growth. Moreover, the heightened awareness about gene therapy and its potential benefits among healthcare professionals and patients is strengthening the market growth. Apart from this, the growing strategic alliances and collaborations among universities, research institutions, and companies to boost innovation and broaden the potential for commercialization are catalyzing the market growth. In addition, the escalating geriatric population, which is highly susceptible to various age-related diseases, such as Parkinson's disease, osteoarthritis, Alzheimer's disease, and age-related macular degeneration (AMD), is fueling the market growth. Other factors, including rising healthcare expenditure, growing adoption of precision medicines, and increasing demand for innovative therapies, are anticipated to drive the market growth.

Japan Gene Therapy Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the Japan gene therapy market report, along with forecasts at the country levels for 2024-2032. Our report has categorized the market based on gene type, vector type, delivery method, and application.

Gene Type Insights:

  • Antigen
  • Cytokine
  • Tumor Suppressor
  • Suicide Gene
  • Deficiency
  • Growth Factors
  • Receptors
  • Others
     

The report has provided a detailed breakup and analysis of the Japan gene therapy market based on gene type. This includes antigen, cytokine, tumor suppressor, suicide gene, deficiency, growth factors, receptors, and others.

Vector Type Insights:

  • Viral Vector 
    • Adenoviruses
    • Lentiviruses
    • Retroviruses
    • Adeno-Associated Virus
    • Herpes Simplex Virus
    • Poxvirus
    • Vaccinia Virus
    • Others
  • Non-Viral Techniques 
    • Naked and Plasmid Vectors
    • Gene Gun
    • Electroporation
    • Lipofection
    • Others
       

A detailed breakup and analysis of the Japan gene therapy market based on the vector type has also been provided in the report. This includes viral vector (adenoviruses, lentiviruses, retroviruses, adeno-associated virus, herpes simplex virus, poxvirus, vaccinia virus, and others) and non-viral techniques (naked and plasmid vectors, gene gun, electroporation, lipofection, and others).

Delivery Method Insights:

  • In-Vivo Gene Therapy
  • Ex-Vivo Gene Therapy
     

The report has provided a detailed breakup and analysis of the Japan gene therapy market based on the delivery method. This includes in-vivo and ex-vivo gene therapy.

Application Insights:

  • Oncological Disorders
  • Rare diseases
  • Cardiovascular Diseases
  • Neurological Disorders
  • Infectious Disease
  • Others
     

The report has provided a detailed breakup and analysis of the Japan gene therapy market based on the application. This includes oncological disorders, rare diseases, cardiovascular diseases, neurological disorders, infectious disease, and others.

Regional Insights:

  • Kanto Region
  • Kinki Region
  • Central/Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
     

The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kinki Region, Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the Japan gene therapy market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Japan Gene Therapy Market Report Scope:

Report Features Details
Base Year of the Analysis 2023
 Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
  • Gene Type
  • Vector Type
  • Delivery Method
  • Application
  • Region
Gene Types Covered Antigen, Cytokine, Tumor Suppressor, Suicide Gene, Deficiency, Growth Factors, Receptors, Others
Vector Types Covered
  • Viral Vector: Adenoviruses, Lentiviruses, Retroviruses, Adeno-Associated Virus, Herpes Simplex Virus, Poxvirus, Vaccinia Virus, Others
  • Non-Viral Techniques: Naked and Plasmid Vectors, Gene Gun, Electroporation, Lipofection, Others
Delivery Methods Covered In-Vivo Gene Therapy, Ex-Vivo Gene Therapy
Applications Covered Oncological Disorders, Rare diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, Others
Regions Covered Kanto Region, Kinki Region, Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, Shikoku Region
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the Japan gene therapy market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan gene therapy market?
  • What is the breakup of the Japan gene therapy market on the basis of gene type?
  • What is the breakup of the Japan gene therapy market on the basis of vector type?
  • What is the breakup of the Japan gene therapy market on the basis of delivery method?
  • What is the breakup of the Japan gene therapy market on the basis of application?
  • What are the various stages in the value chain of the Japan gene therapy market?
  • What are the key driving factors and challenges in the Japan gene therapy market?
  • What is the structure of the Japan gene therapy market and who are the key players?
  • What is the degree of competition in the Japan gene therapy market?

Key Benefits for Stakeholders:

  • IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Japan gene therapy market from 2018-2032.
  • The research study provides the latest information on the market drivers, challenges, and opportunities in the Japan gene therapy market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Japan gene therapy industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Japan Gene Therapy Market Report by Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide Gene, Deficiency, Growth Factors, Receptors, and Others), Vector Type (Viral Vector, Non-Viral Techniques), Delivery Method (In-Vivo Gene Therapy, Ex-Vivo Gene Therapy), Application (Oncological Disorders, Rare diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More